Here are three notes:
1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.
2. Exatech’s board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.
3. When the deal was announced Oct. 23, Exatech’s stock has hovered at $42. However, on Monday, Dec. 4, the company’s stock was trading at $49.25.
More articles on devices and implants:
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
Mazor Robotics CEO under investigation for insider trading: 3 things to know
Precision Medical opens 3rd Indiana location — 6 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
